Ozanezumab (GSK1223249) is a sophisticated humanized IgG1 monoclonal antibody target the neurite outgrowth inhibitor A (Nogo-A), thereby facilitating neuronal regeneration and functional recovery through high-affinity binding to its specific protein target for the research of amyotrophic lateral sclerosis and multiple sclerosis.
Reinheit:
95.00%
CAS Nummer:
[1310680-64-8]
Target-Kategorie:
Others
T81580
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten